Empress Therapeutics

Empress Therapeutics is a drug discovery startup founded in 2020 and incubated by Flagship Pioneering. The company is establishing a new paradigm for small molecule drug discovery by studying the chemical information of DNA in the human body, enabling rapid, predictable, and low-cost development of small molecule drugs.